Strongyloides stercoralis: The Human Threadworm
Strongyloides stercoralis is a human pathogenic parasitic roundworm belonging to the group of nematodes, commonly known as a threadworm. The infection it causes is called strongyloidiasis. This parasite is unique among human nematodes due to its complex life cycle, which includes an alternation between free-living and parasitic cycles, and its remarkable ability to cause autoinfection within the host. This autoinfective capacity allows the organism to perpetuate the infection for decades, leading to chronic strongyloidiasis, even after the host has left an endemic area. It is classified as a soil-transmitted helminth and is predominantly found in warm, moist, tropical, and subtropical areas globally, where sanitation infrastructure is poor. Current estimates suggest that S. stercoralis infects over 600 million people worldwide, making it a significant global health concern, particularly in low-resource settings. The worm primarily infects humans but also occurs naturally in domestic dogs, cats, and primates.
The Unique and Complex Life Cycle
The life cycle of S. stercoralis comprises two main phases: a free-living phase in the soil and a parasitic phase within the human host. The cycle begins with the parasitic phase when infective third-stage larvae (iL3s), called filariform larvae, in contaminated soil penetrate exposed human skin, typically the feet. These larvae are barely visible to the naked eye. Once they penetrate the skin, they migrate via the bloodstream or lymphatics to the lungs, where they enter the alveoli. From the lungs, they travel up the trachea and are eventually coughed up and swallowed into the alimentary canal. They then reach the proximal small intestine, where they invade the intestinal mucosa.
In the small intestine, the larvae mature into adult female worms. These adult females live threaded in the epithelium of the small intestine and reproduce by parthenogenesis (without fertilization), depositing eggs within the mucosa. The eggs hatch inside the intestinal mucosa and release rhabditiform larvae (non-infective first-stage larvae) that move into the intestinal lumen. Most of these rhabditiform larvae are passed out of the body in the feces into the soil. Once in the soil, the excreted rhabditiform larvae have two options for their life cycle.
The free-living cycle, or heterogonic cycle, is completed when the rhabditiform larvae develop into free-living adult male and female worms, which reproduce sexually to give rise to a new generation of infective filariform larvae. This allows the parasite to multiply in the environment in the absence of a host. Alternatively, the rhabditiform larvae in the soil can directly mature into infective filariform larvae, which then wait to penetrate a new human host’s skin to continue the parasitic cycle, which is referred to as the homogonic cycle.
The Critical Role of Autoinfection
The most distinctive and clinically significant feature of S. stercoralis is its potential for autoinfection. In this process, some rhabditiform larvae, instead of being passed in the stool, mature prematurely into infective filariform larvae while still inside the host’s intestinal lumen. These newly hatched larvae can then penetrate the intestinal mucosa or the perianal skin, re-entering the bloodstream and initiating a new parasitic cycle within the same host. This internal reinfection mechanism is generally limited by a healthy, intact immune response. However, even in an immunocompetent host, a low level of autoinfection can occur and, subsequently, cause chronic infections for decades. This persistent, often subclinical infection poses a profound risk if the host later becomes immunosuppressed, as the autoinfection cycle can accelerate rapidly.
Clinical Manifestations of Strongyloidiasis
The manifestations of strongyloidiasis range from completely asymptomatic to life-threatening. Most people infected with Strongyloides do not have any symptoms, particularly in the chronic phase. In an acute, uncomplicated infection, patients may first notice a localized, pruritic, erythematous rash (“ground itch”) at the site of larval skin penetration, usually on the feet. As larvae migrate through the lungs, patients may experience a dry cough, wheezing, and occasionally pneumonia-like symptoms (Löffler’s syndrome). Once the worms are established in the gut, gastrointestinal symptoms can include upper abdominal pain (mimicking a peptic ulcer), heartburn, bloating, and an alternating pattern of diarrhea and constipation, along with loss of appetite and weight loss.
In chronic strongyloidiasis, symptoms are often intermittent or absent. A notable skin symptom in both chronic and acute phases is “larva currens” (running larva), a raised, red, itchy, scratch-like rash caused by the rapid migration of larvae within the skin, which is often seen on the trunk, buttocks, or thighs. Persistent infection can lead to an inability to absorb nutrients normally, resulting in malnutrition.
Hyperinfection and Disseminated Disease
The most dangerous manifestation is Strongyloidiasis Hyperinfection Syndrome or Disseminated Strongyloidiasis. These severe forms are most frequently associated with subclinical, chronic infection in patients who become immunocompromised, particularly those receiving high-dose corticosteroids, or who have underlying conditions like HIV/AIDS or HTLV-1 infection. The weakened immune system loses the ability to limit the autoinfection cycle, leading to a massive, overwhelming increase in the number of migrating larvae.
In hyperinfection syndrome, the massive parasitic load is still largely confined to the gastrointestinal tract and lungs, but the severity of symptoms escalates drastically, causing severe abdominal pain, bloody diarrhea, and potentially fatal pulmonary complications like hemoptysis (coughing up blood) and severe shortness of breath. Disseminated strongyloidiasis is even more severe, occurring when the larvae invade numerous extra-intestinal organs not normally part of the life cycle, such as the heart, central nervous system (leading to stiff neck, confusion), and urinary tract. Both hyperinfection and disseminated disease often have a poor prognosis, can lead to sepsis, and are frequently life-threatening if not aggressively treated.
Diagnosis and Treatment
Diagnosis of strongyloidiasis can be challenging because of the characteristic low larval count in stool specimens, especially in chronic cases. Healthcare providers typically use a combination of diagnostic methods. Strongyloides serology, a blood test that detects antibodies to S. stercoralis, is often the most reliable method for diagnosing chronic infection. Microscopic examination of stool samples to look for rhabditiform larvae is also performed, and sometimes requires multiple samples due to the intermittent shedding of larvae. In cases of severe infection, larvae may be found in sputum samples or through duodenal aspiration.
The goal of treatment is to eliminate the parasitic worms using antiparasitic drugs, also known as anthelminthics. Ivermectin at a single or repeat dose is the treatment of choice for uncomplicated strongyloidiasis, sometimes combined with albendazole. Because Ivermectin is more effective against the adult worms than the larval forms, repeat dosing is often necessary to completely eradicate the infection and prevent the risk of hyperinfection, which is a critical consideration for individuals about to start or already on immunosuppressive drugs.